Overview

To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

Status:
Completed
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
An open label study to evaluate drug-drug interactions between HEC585 and Pirfenidone or Nintedanib in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Sunshine Lake Pharma Co., Ltd.
Treatments:
Nintedanib
Pirfenidone